Fertility medication (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Fertility medication" in English language version.

refsWebsite

Global rank English rank

36nih.gov

4^th place

27doi.org

2^nd place

7semanticscholar.org

11^th place

8^th place

1springer.com

274^th place

309^th place

1nice.org.uk

3,258^th place

2,666^th place

1rero.ch

3,510^th place

2,263^rd place

1worldcat.org

5^th place

doi.org

Dancet EA, Fleur Dancet EA, D'Hooghe TM, d'Hooghe TM, van der Veen F, Bossuyt P, et al. (April 2014). ""Patient-centered fertility treatment": what is required?". Fertility and Sterility. 101 (4): 924–6. doi:10.1016/j.fertnstert.2013.12.045. PMID 24502889.
Stute P, Birkhauser M (2015). "Selective estrogen receptor modulators (SERM)/Selektive Ostrogenrezeptormodulatoren (SERM)" (PDF). Gynakologische Endokrinologie. 13 (2): 126. doi:10.1007/s10304-015-0003-9. S2CID 23400904.
Fauser BC (December 2014). "Reproductive endocrinology: revisiting ovulation induction in PCOS". Nature Reviews. Endocrinology. 10 (12): 704–5. doi:10.1038/nrendo.2014.156. PMID 25178733. S2CID 8380091.
Goldstein SR, Siddhanti S, Ciaccia AV, Plouffe L (2000). "A pharmacological review of selective oestrogen receptor modulators". Human Reproduction Update. 6 (3): 212–24. doi:10.1093/humupd/6.3.212. PMID 10874566.
Dickey RP, Holtkamp DE (1996). "Development, pharmacology and clinical experience with clomiphene citrate". Human Reproduction Update. 2 (6): 483–506. doi:10.1093/humupd/2.6.483. PMID 9111183.
Gorlitsky GA, Kase NG, Speroff L (March 1978). "Ovulation and pregnancy rates with clomiphene citrate". Obstetrics and Gynecology. 51 (3): 265–9. doi:10.1097/00006250-197803000-00002. PMID 628527.
Gysler M, March CM, Mishell DR, Bailey EJ (February 1982). "A decade's experience with an individualized clomiphene treatment regimen including its effect on the postcoital test". Fertility and Sterility. 37 (2): 161–7. doi:10.1016/s0015-0282(16)46033-4. PMID 7060766.
Franik, Sebastian; Le, Quang-Khoi; Kremer, Jan Am; Kiesel, Ludwig; Farquhar, Cindy (2022-09-27). "Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome". The Cochrane Database of Systematic Reviews. 2022 (9): CD010287. doi:10.1002/14651858.CD010287.pub4. ISSN 1469-493X. PMC 9514207. PMID 36165742.
Conforti A, Esteves SC, Di Rella F, Strina I, De Rosa P, Fiorenza A, et al. (February 2019). "The role of recombinant LH in women with hypo-response to controlled ovarian stimulation: a systematic review and meta-analysis". Reproductive Biology and Endocrinology. 17 (1): 18. doi:10.1186/s12958-019-0460-4. PMC 6366097. PMID 30728019.
Weiss NS, Kostova E, Nahuis M, Mol BW, van der Veen F, van Wely M (January 2019). "Gonadotrophins for ovulation induction in women with polycystic ovary syndrome". The Cochrane Database of Systematic Reviews. 1 (1): CD010290. doi:10.1002/14651858.CD010290.pub3. PMC 6353048. PMID 30648738.
Hickman LC, Llarena NC, Valentine LN, Liu X, Falcone T (April 2018). "Preservation of gonadal function in women undergoing chemotherapy: a systematic review and meta-analysis of the potential role for gonadotropin-releasing hormone agonists". Journal of Assisted Reproduction and Genetics. 35 (4): 571–581. doi:10.1007/s10815-018-1128-2. PMC 5949114. PMID 29470701.
Bedaiwy MA, Abou-Setta AM, Desai N, Hurd W, Starks D, El-Nashar SA, et al. (March 2011). "Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function during gonadotoxic chemotherapy: a systematic review and meta-analysis". Fertility and Sterility. 95 (3): 906–14.e1–4. doi:10.1016/j.fertnstert.2010.11.017. PMID 21145541.
Leão R, Esteves SC (2014). "Gonadotropin therapy in assisted reproduction: an evolutionary perspective from biologics to biotech". Clinics (Review). 69 (4): 279–93. doi:10.6061/clinics/2014(04)10. PMC 3971356. PMID 24714837.
Penzias A, Bendikson K, Butts S, Coutifaris C, Falcone T, Fossum G, et al. (September 2017). "Role of metformin for ovulation induction in infertile patients with polycystic ovary syndrome (PCOS): a guideline". Fertility and Sterility. 108 (3): 426–441. doi:10.1016/j.fertnstert.2017.06.026. PMID 28865539.
de Kretser DM (March 1997). "Male infertility". Lancet (Review). 349 (9054): 787–90. doi:10.1016/s0140-6736(96)08341-9. PMID 9074589. S2CID 12928678.
Ribeiro MA, Gameiro LF, Scarano WR, Briton-Jones C, Kapoor A, Rosa MB, El Dib R (May 2016). "Aromatase inhibitors in the treatment of oligozoospermic or azoospermic men: a systematic review of randomized controlled trials". JBRA Assisted Reproduction (Review). 20 (2): 82–8. doi:10.5935/1518-0557.20160019. PMID 27244767.
Willets AE, Corbo JM, Brown JN (July 2013). "Clomiphene for the treatment of male infertility". Reproductive Sciences (Review). 20 (7): 739–44. doi:10.1177/1933719112466304. PMID 23202725. S2CID 206804686.
Buhling K, Schumacher A, Eulenburg CZ, Laakmann E (August 2019). "Influence of oral vitamin and mineral supplementation on male infertility: a meta-analysis and systematic review". Reproductive Biomedicine Online. 39 (2): 269–279. doi:10.1016/j.rbmo.2019.03.099. PMID 31160241.
Arab A, Hadi A, Moosavian SP, Askari G, Nasirian M (November 2019). "The association between serum vitamin D, fertility and semen quality: A systematic review and meta-analysis". International Journal of Surgery. 71: 101–109. doi:10.1016/j.ijsu.2019.09.025. PMID 31561004. S2CID 203580672.
Smits RM, Mackenzie-Proctor R, Fleischer K, Showell MG (September 2018). "Antioxidants in fertility: impact on male and female reproductive outcomes". Fertility and Sterility. 110 (4): 578–580. doi:10.1016/j.fertnstert.2018.05.028. PMID 30196940.
Chehab M, Madala A, Trussell JC (March 2015). "On-label and off-label drugs used in the treatment of male infertility". Fertility and Sterility (Review). 103 (3): 595–604. doi:10.1016/j.fertnstert.2014.12.122. PMID 25660648.
Fazeli Z, Abedindo A, Omrani MD, Ghaderian SM (February 2018). "Mesenchymal Stem Cells (MSCs) Therapy for Recovery of Fertility: a Systematic Review". Stem Cell Reviews and Reports. 14 (1): 1–12. doi:10.1007/s12015-017-9765-x. PMID 28884412. S2CID 44236281.
Rizzuto I, Behrens RF, Smith LA (June 2019). "Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility". The Cochrane Database of Systematic Reviews. 2019 (6): CD008215. doi:10.1002/14651858.cd008215.pub3. PMC 6579663. PMID 31207666.
Kroener L, Dumesic D, Al-Safi Z (August 2017). "Use of fertility medications and cancer risk: a review and update". Current Opinion in Obstetrics & Gynecology. 29 (4): 195–201. doi:10.1097/GCO.0000000000000370. PMC 5551049. PMID 28538003.
Rudant J, Amigou A, Orsi L, Althaus T, Leverger G, Baruchel A, et al. (February 2013). "Fertility treatments, congenital malformations, fetal loss, and childhood acute leukemia: the ESCALE study (SFCE)". Pediatric Blood & Cancer. 60 (2): 301–308. doi:10.1002/pbc.24192. PMID 22610722. S2CID 26010916.
Banker M, Garcia-Velasco JA (2015). "Revisiting ovarian hyper stimulation syndrome: Towards OHSS free clinic". J Hum Reprod Sci. 8 (1): 13–7. doi:10.4103/0974-1208.153120. PMC 4381376. PMID 25838743.
Gameiro S, Boivin J, Peronace L, Verhaak CM (August 2012). "Why do patients discontinue fertility treatment? A systematic review of reasons and predictors of discontinuation in fertility treatment". Human Reproduction Update. 18 (6): 652–69. doi:10.1093/humupd/dms031. PMC 3461967. PMID 22869759.

nice.org.uk

guidance.nice.org.uk

"Fertility problems: assessment and treatment". NICE clinical guideline CG156. U.K. National Institute for Health and Care Excellence (NICE). February 2013.

nih.gov

pubmed.ncbi.nlm.nih.gov

Dancet EA, Fleur Dancet EA, D'Hooghe TM, d'Hooghe TM, van der Veen F, Bossuyt P, et al. (April 2014). ""Patient-centered fertility treatment": what is required?". Fertility and Sterility. 101 (4): 924–6. doi:10.1016/j.fertnstert.2013.12.045. PMID 24502889.
Fauser BC (December 2014). "Reproductive endocrinology: revisiting ovulation induction in PCOS". Nature Reviews. Endocrinology. 10 (12): 704–5. doi:10.1038/nrendo.2014.156. PMID 25178733. S2CID 8380091.
Goldstein SR, Siddhanti S, Ciaccia AV, Plouffe L (2000). "A pharmacological review of selective oestrogen receptor modulators". Human Reproduction Update. 6 (3): 212–24. doi:10.1093/humupd/6.3.212. PMID 10874566.
Dickey RP, Holtkamp DE (1996). "Development, pharmacology and clinical experience with clomiphene citrate". Human Reproduction Update. 2 (6): 483–506. doi:10.1093/humupd/2.6.483. PMID 9111183.
Gorlitsky GA, Kase NG, Speroff L (March 1978). "Ovulation and pregnancy rates with clomiphene citrate". Obstetrics and Gynecology. 51 (3): 265–9. doi:10.1097/00006250-197803000-00002. PMID 628527.
Gysler M, March CM, Mishell DR, Bailey EJ (February 1982). "A decade's experience with an individualized clomiphene treatment regimen including its effect on the postcoital test". Fertility and Sterility. 37 (2): 161–7. doi:10.1016/s0015-0282(16)46033-4. PMID 7060766.
Franik, Sebastian; Le, Quang-Khoi; Kremer, Jan Am; Kiesel, Ludwig; Farquhar, Cindy (2022-09-27). "Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome". The Cochrane Database of Systematic Reviews. 2022 (9): CD010287. doi:10.1002/14651858.CD010287.pub4. ISSN 1469-493X. PMC 9514207. PMID 36165742.
Conforti A, Esteves SC, Di Rella F, Strina I, De Rosa P, Fiorenza A, et al. (February 2019). "The role of recombinant LH in women with hypo-response to controlled ovarian stimulation: a systematic review and meta-analysis". Reproductive Biology and Endocrinology. 17 (1): 18. doi:10.1186/s12958-019-0460-4. PMC 6366097. PMID 30728019.
Weiss NS, Kostova E, Nahuis M, Mol BW, van der Veen F, van Wely M (January 2019). "Gonadotrophins for ovulation induction in women with polycystic ovary syndrome". The Cochrane Database of Systematic Reviews. 1 (1): CD010290. doi:10.1002/14651858.CD010290.pub3. PMC 6353048. PMID 30648738.
Hickman LC, Llarena NC, Valentine LN, Liu X, Falcone T (April 2018). "Preservation of gonadal function in women undergoing chemotherapy: a systematic review and meta-analysis of the potential role for gonadotropin-releasing hormone agonists". Journal of Assisted Reproduction and Genetics. 35 (4): 571–581. doi:10.1007/s10815-018-1128-2. PMC 5949114. PMID 29470701.
Bedaiwy MA, Abou-Setta AM, Desai N, Hurd W, Starks D, El-Nashar SA, et al. (March 2011). "Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function during gonadotoxic chemotherapy: a systematic review and meta-analysis". Fertility and Sterility. 95 (3): 906–14.e1–4. doi:10.1016/j.fertnstert.2010.11.017. PMID 21145541.
Leão R, Esteves SC (2014). "Gonadotropin therapy in assisted reproduction: an evolutionary perspective from biologics to biotech". Clinics (Review). 69 (4): 279–93. doi:10.6061/clinics/2014(04)10. PMC 3971356. PMID 24714837.
Penzias A, Bendikson K, Butts S, Coutifaris C, Falcone T, Fossum G, et al. (September 2017). "Role of metformin for ovulation induction in infertile patients with polycystic ovary syndrome (PCOS): a guideline". Fertility and Sterility. 108 (3): 426–441. doi:10.1016/j.fertnstert.2017.06.026. PMID 28865539.
de Kretser DM (March 1997). "Male infertility". Lancet (Review). 349 (9054): 787–90. doi:10.1016/s0140-6736(96)08341-9. PMID 9074589. S2CID 12928678.
Ribeiro MA, Gameiro LF, Scarano WR, Briton-Jones C, Kapoor A, Rosa MB, El Dib R (May 2016). "Aromatase inhibitors in the treatment of oligozoospermic or azoospermic men: a systematic review of randomized controlled trials". JBRA Assisted Reproduction (Review). 20 (2): 82–8. doi:10.5935/1518-0557.20160019. PMID 27244767.
Willets AE, Corbo JM, Brown JN (July 2013). "Clomiphene for the treatment of male infertility". Reproductive Sciences (Review). 20 (7): 739–44. doi:10.1177/1933719112466304. PMID 23202725. S2CID 206804686.
Buhling K, Schumacher A, Eulenburg CZ, Laakmann E (August 2019). "Influence of oral vitamin and mineral supplementation on male infertility: a meta-analysis and systematic review". Reproductive Biomedicine Online. 39 (2): 269–279. doi:10.1016/j.rbmo.2019.03.099. PMID 31160241.
Irani M, Amirian M, Sadeghi R, Lez JL, Latifnejad Roudsari R (August 2017). "The Effect of Folate and Folate Plus Zinc Supplementation on Endocrine Parameters and Sperm Characteristics in Sub-Fertile Men: A Systematic Review and Meta-Analysis". Urology Journal. 14 (5): 4069–4078. PMID 28853101.
Arab A, Hadi A, Moosavian SP, Askari G, Nasirian M (November 2019). "The association between serum vitamin D, fertility and semen quality: A systematic review and meta-analysis". International Journal of Surgery. 71: 101–109. doi:10.1016/j.ijsu.2019.09.025. PMID 31561004. S2CID 203580672.
Smits RM, Mackenzie-Proctor R, Fleischer K, Showell MG (September 2018). "Antioxidants in fertility: impact on male and female reproductive outcomes". Fertility and Sterility. 110 (4): 578–580. doi:10.1016/j.fertnstert.2018.05.028. PMID 30196940.
Chehab M, Madala A, Trussell JC (March 2015). "On-label and off-label drugs used in the treatment of male infertility". Fertility and Sterility (Review). 103 (3): 595–604. doi:10.1016/j.fertnstert.2014.12.122. PMID 25660648.
Fazeli Z, Abedindo A, Omrani MD, Ghaderian SM (February 2018). "Mesenchymal Stem Cells (MSCs) Therapy for Recovery of Fertility: a Systematic Review". Stem Cell Reviews and Reports. 14 (1): 1–12. doi:10.1007/s12015-017-9765-x. PMID 28884412. S2CID 44236281.
Rizzuto I, Behrens RF, Smith LA (June 2019). "Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility". The Cochrane Database of Systematic Reviews. 2019 (6): CD008215. doi:10.1002/14651858.cd008215.pub3. PMC 6579663. PMID 31207666.
Kroener L, Dumesic D, Al-Safi Z (August 2017). "Use of fertility medications and cancer risk: a review and update". Current Opinion in Obstetrics & Gynecology. 29 (4): 195–201. doi:10.1097/GCO.0000000000000370. PMC 5551049. PMID 28538003.
Rudant J, Amigou A, Orsi L, Althaus T, Leverger G, Baruchel A, et al. (February 2013). "Fertility treatments, congenital malformations, fetal loss, and childhood acute leukemia: the ESCALE study (SFCE)". Pediatric Blood & Cancer. 60 (2): 301–308. doi:10.1002/pbc.24192. PMID 22610722. S2CID 26010916.
Banker M, Garcia-Velasco JA (2015). "Revisiting ovarian hyper stimulation syndrome: Towards OHSS free clinic". J Hum Reprod Sci. 8 (1): 13–7. doi:10.4103/0974-1208.153120. PMC 4381376. PMID 25838743.
Gameiro S, Boivin J, Peronace L, Verhaak CM (August 2012). "Why do patients discontinue fertility treatment? A systematic review of reasons and predictors of discontinuation in fertility treatment". Human Reproduction Update. 18 (6): 652–69. doi:10.1093/humupd/dms031. PMC 3461967. PMID 22869759.

ncbi.nlm.nih.gov

Franik, Sebastian; Le, Quang-Khoi; Kremer, Jan Am; Kiesel, Ludwig; Farquhar, Cindy (2022-09-27). "Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome". The Cochrane Database of Systematic Reviews. 2022 (9): CD010287. doi:10.1002/14651858.CD010287.pub4. ISSN 1469-493X. PMC 9514207. PMID 36165742.
Conforti A, Esteves SC, Di Rella F, Strina I, De Rosa P, Fiorenza A, et al. (February 2019). "The role of recombinant LH in women with hypo-response to controlled ovarian stimulation: a systematic review and meta-analysis". Reproductive Biology and Endocrinology. 17 (1): 18. doi:10.1186/s12958-019-0460-4. PMC 6366097. PMID 30728019.
Weiss NS, Kostova E, Nahuis M, Mol BW, van der Veen F, van Wely M (January 2019). "Gonadotrophins for ovulation induction in women with polycystic ovary syndrome". The Cochrane Database of Systematic Reviews. 1 (1): CD010290. doi:10.1002/14651858.CD010290.pub3. PMC 6353048. PMID 30648738.
Hickman LC, Llarena NC, Valentine LN, Liu X, Falcone T (April 2018). "Preservation of gonadal function in women undergoing chemotherapy: a systematic review and meta-analysis of the potential role for gonadotropin-releasing hormone agonists". Journal of Assisted Reproduction and Genetics. 35 (4): 571–581. doi:10.1007/s10815-018-1128-2. PMC 5949114. PMID 29470701.
Leão R, Esteves SC (2014). "Gonadotropin therapy in assisted reproduction: an evolutionary perspective from biologics to biotech". Clinics (Review). 69 (4): 279–93. doi:10.6061/clinics/2014(04)10. PMC 3971356. PMID 24714837.
Rizzuto I, Behrens RF, Smith LA (June 2019). "Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility". The Cochrane Database of Systematic Reviews. 2019 (6): CD008215. doi:10.1002/14651858.cd008215.pub3. PMC 6579663. PMID 31207666.
Kroener L, Dumesic D, Al-Safi Z (August 2017). "Use of fertility medications and cancer risk: a review and update". Current Opinion in Obstetrics & Gynecology. 29 (4): 195–201. doi:10.1097/GCO.0000000000000370. PMC 5551049. PMID 28538003.
Banker M, Garcia-Velasco JA (2015). "Revisiting ovarian hyper stimulation syndrome: Towards OHSS free clinic". J Hum Reprod Sci. 8 (1): 13–7. doi:10.4103/0974-1208.153120. PMC 4381376. PMID 25838743.
Gameiro S, Boivin J, Peronace L, Verhaak CM (August 2012). "Why do patients discontinue fertility treatment? A systematic review of reasons and predictors of discontinuation in fertility treatment". Human Reproduction Update. 18 (6): 652–69. doi:10.1093/humupd/dms031. PMC 3461967. PMID 22869759.

rero.ch

doc.rero.ch

Stute P, Birkhauser M (2015). "Selective estrogen receptor modulators (SERM)/Selektive Ostrogenrezeptormodulatoren (SERM)" (PDF). Gynakologische Endokrinologie. 13 (2): 126. doi:10.1007/s10304-015-0003-9. S2CID 23400904.

semanticscholar.org

api.semanticscholar.org

Stute P, Birkhauser M (2015). "Selective estrogen receptor modulators (SERM)/Selektive Ostrogenrezeptormodulatoren (SERM)" (PDF). Gynakologische Endokrinologie. 13 (2): 126. doi:10.1007/s10304-015-0003-9. S2CID 23400904.
Fauser BC (December 2014). "Reproductive endocrinology: revisiting ovulation induction in PCOS". Nature Reviews. Endocrinology. 10 (12): 704–5. doi:10.1038/nrendo.2014.156. PMID 25178733. S2CID 8380091.
de Kretser DM (March 1997). "Male infertility". Lancet (Review). 349 (9054): 787–90. doi:10.1016/s0140-6736(96)08341-9. PMID 9074589. S2CID 12928678.
Willets AE, Corbo JM, Brown JN (July 2013). "Clomiphene for the treatment of male infertility". Reproductive Sciences (Review). 20 (7): 739–44. doi:10.1177/1933719112466304. PMID 23202725. S2CID 206804686.
Arab A, Hadi A, Moosavian SP, Askari G, Nasirian M (November 2019). "The association between serum vitamin D, fertility and semen quality: A systematic review and meta-analysis". International Journal of Surgery. 71: 101–109. doi:10.1016/j.ijsu.2019.09.025. PMID 31561004. S2CID 203580672.
Fazeli Z, Abedindo A, Omrani MD, Ghaderian SM (February 2018). "Mesenchymal Stem Cells (MSCs) Therapy for Recovery of Fertility: a Systematic Review". Stem Cell Reviews and Reports. 14 (1): 1–12. doi:10.1007/s12015-017-9765-x. PMID 28884412. S2CID 44236281.
Rudant J, Amigou A, Orsi L, Althaus T, Leverger G, Baruchel A, et al. (February 2013). "Fertility treatments, congenital malformations, fetal loss, and childhood acute leukemia: the ESCALE study (SFCE)". Pediatric Blood & Cancer. 60 (2): 301–308. doi:10.1002/pbc.24192. PMID 22610722. S2CID 26010916.

springer.com

Drobnis EZ, Nangia AK (2017). Impacts of Medications on Male Fertility. Cham, Switzerland: Palgrave Macmillan. ISBN 978-3-319-69535-8. Retrieved 23 February 2019.

worldcat.org

search.worldcat.org

Franik, Sebastian; Le, Quang-Khoi; Kremer, Jan Am; Kiesel, Ludwig; Farquhar, Cindy (2022-09-27). "Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome". The Cochrane Database of Systematic Reviews. 2022 (9): CD010287. doi:10.1002/14651858.CD010287.pub4. ISSN 1469-493X. PMC 9514207. PMID 36165742.